Stemsation International Stock Performance
| STSN Stock | USD 0.02 0 11.54% |
Stemsation International holds a performance score of 6 on a scale of zero to a hundred. The entity has a beta of -4.33, which indicates a somewhat significant risk relative to the market. As returns on the market increase, returns on owning Stemsation International are expected to decrease by larger amounts. On the other hand, during market turmoil, Stemsation International is expected to outperform it. Use Stemsation International sortino ratio, as well as the relationship between the semi variance and day median price , to analyze future returns on Stemsation International.
Risk-Adjusted Performance
6 of 100
Weak | Strong |
Modest
Compared to the overall equity markets, risk-adjusted returns on investments in Stemsation International are ranked lower than 6 (%) of all global equities and portfolios over the last 90 days. In spite of very weak basic indicators, Stemsation International displayed solid returns over the last few months and may actually be approaching a breakup point. ...more
Stemsation |
Stemsation International Relative Risk vs. Return Landscape
If you would invest 2.11 in Stemsation International on September 12, 2024 and sell it today you would lose (0.50) from holding Stemsation International or give up 23.7% of portfolio value over 90 days. Stemsation International is currently generating 1.627% in daily expected returns and assumes 20.3374% risk (volatility on return distribution) over the 90 days horizon. In different words, most equities are less risky than Stemsation, and most traded equity instruments are projected to make higher returns than the company over the 90 days investment horizon. Expected Return |
| Risk |
Stemsation International Market Risk Analysis
Today, many novice investors tend to focus exclusively on investment returns with little concern for Stemsation International's investment risk. Standard deviation is the most common way to measure market volatility of pink sheets, such as Stemsation International, and traders can use it to determine the average amount a Stemsation International's price has deviated from the expected return over a period of time. It is calculated by determining the expected price for the established period and then subtracting this figure from each price point. The differences are then squared, summed, and averaged to produce the variance.
Sharpe Ratio = 0.08
| Best Portfolio | Best Equity | |||
| Good Returns | ||||
| Average Returns | STSN | |||
| Small Returns | ||||
| Cash | Small Risk | Average Risk | High Risk | Huge Risk |
| Negative Returns |
Estimated Market Risk
| 20.34 actual daily | 96 96% of assets are less volatile |
Expected Return
| 1.63 actual daily | 32 68% of assets have higher returns |
Risk-Adjusted Return
| 0.08 actual daily | 6 94% of assets perform better |
Based on monthly moving average Stemsation International is performing at about 6% of its full potential. If added to a well diversified portfolio the total return can be enhanced and market risk can be reduced. You can increase risk-adjusted return of Stemsation International by adding it to a well-diversified portfolio.
Stemsation International Fundamentals Growth
Stemsation Pink Sheet prices reflect investors' perceptions of the future prospects and financial health of Stemsation International, and Stemsation International fundamentals are critical determinants of its market performance. Overall, investors pay close attention to revenue and earnings growth, profit margins, and debt levels. These fundamentals can have a significant impact on Stemsation Pink Sheet performance.
| Current Valuation | 3.81 M | |||
| Shares Outstanding | 24.76 M | |||
| Price To Sales | 727.92 X | |||
| Cash And Equivalents | 178 | |||
| Total Debt | 339.98 K | |||
| Book Value Per Share | (0) X | |||
| Cash Flow From Operations | (181) | |||
| Earnings Per Share | (0) X | |||
| Total Asset | 1.92 K | |||
About Stemsation International Performance
By examining Stemsation International's fundamental ratios, stakeholders can obtain critical insights into Stemsation International's financial health, operational efficiency, and overall profitability. These insights assist in making well-informed investment and management decisions. For example, a high Return on Assets and Return on Equity would indicate that Stemsation International is effectively utilizing its assets and equity to generate significant profits, enhancing its appeal to investors. On the other hand, low ROA and ROE values could reveal issues in asset and equity management, highlighting the need for operational improvements.
StemSation International, Inc. develops, manufactures, and distributes natural wellness products that support the stem cell and endocannabinoid systems in the human body. StemSation International, Inc. is headquartered in Boca Raton, Florida. Sternsation International operates under Drug ManufacturersSpecialty Generic classification in the United States and is traded on OTC Exchange.Things to note about Stemsation International performance evaluation
Checking the ongoing alerts about Stemsation International for important developments is a great way to find new opportunities for your next move. Pink Sheet alerts and notifications screener for Stemsation International help investors to be notified of important events, changes in technical or fundamental conditions, and significant headlines that can affect investment decisions.| Stemsation International is way too risky over 90 days horizon | |
| Stemsation International has some characteristics of a very speculative penny stock | |
| Stemsation International appears to be risky and price may revert if volatility continues | |
| Net Loss for the year was (29.58 K) with profit before overhead, payroll, taxes, and interest of 0. | |
| Stemsation International currently holds about 178 in cash with (181) of positive cash flow from operations. |
- Analyzing Stemsation International's financial statements, including its income statement, balance sheet, and cash flow statement, helps in understanding its overall financial health and growth potential.
- Getting a closer look at valuation ratios like price-to-earnings (P/E) ratio, price-to-sales (P/S) ratio, and price-to-book (P/B) ratio help in understanding whether Stemsation International's stock is overvalued or undervalued compared to its peers.
- Examining Stemsation International's industry or sector and how it is performing can give you an idea of its growth potential and how it is positioned relative to its competitors.
- Evaluating Stemsation International's management team can have a significant impact on its success or failure. Reviewing the track record and experience of Stemsation International's management team can help you assess the Company's leadership.
- Pay attention to analyst opinions and ratings of Stemsation International's pink sheet. These opinions can provide insight into Stemsation International's potential for growth and whether the stock is currently undervalued or overvalued.
Other Information on Investing in Stemsation Pink Sheet
Stemsation International financial ratios help investors to determine whether Stemsation Pink Sheet is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Stemsation with respect to the benefits of owning Stemsation International security.